Oxcarbazepine recalls

The FDA has published 9 recalls involving Oxcarbazepine since 2013. The latest was reported on 7 Jun 2023. Most were for potency & assay. Aidapak Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls9since 2013

Last 12 months0reported

Class I111% of total

Ongoing1latest 7 Jun 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 1 11%Class II 7 78%Class III 1 11%

Why oxcarbazepine is recalled

Companies

By year

2023111%
2022111%
2019111%
2014444%
2013222%

Ongoing oxcarbazepine recalls

1 active

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Oxcarbazepine Oral Suspension, USP, 300 mg recalled by Akorn	Akorn	Potency & Assay	Nationwide

All oxcarbazepine recalls, newest first

9 total

Reported	Class	Recall	Company	Reason	Where
7 Jun 2023Drug	CLASS II	Oxcarbazepine Oral Suspension, USP, 300 mg recalled by Akorn	Akorn	Potency & Assay	Nationwide
28 Dec 2022Drug	CLASS II	Oxcarbazepine Tablets 600mg recalled by Sun Pharmaceutical IndustriesOxcarbazepine	SUN Pharmaceutical Industries	Packaging Defects	Nationwide
25 Sep 2019Drug	CLASS II	Oxcarbazepine Oral Suspension, USP, 300 mg recalled	West-Ward Columbus	Potency & Assay	Nationwide
24 Sep 2014Drug	CLASS I	Oxcarbazepine Tablets, 300 mg per carton (10 recalled	American Health Packaging	Packaging Defects	Nationwide
19 Feb 2014Drug	CLASS II	Oxcarbazepine Tablets, 300 mg recalled by Caraco PharmaceuticalOxcarbazepine	Caraco Pharmaceutical Laboratories	Packaging Defects	Nationwide
22 Jan 2014Drug	CLASS II	OXcarbazepine Tablet, 600 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states
22 Jan 2014Drug	CLASS II	OXcarbazepine Tablet, 150 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states
18 Dec 2013Drug	CLASS III	Oxcarbazepine Tablets, 150 mg recalled by Boehringer Ingelheim Roxane	Boehringer Ingelheim Roxane	Potency & Assay	Nationwide
27 Nov 2013Drug	CLASS II	Oxcarbazepine Oral Suspension, 300 mg recalled	Boehringer Ingelheim Roxane	Other	Nationwide

Should you stop taking Oxcarbazepine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.